ProfileGDS4718 / 201144_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 96% 92% 95% 94% 92% 97% 97% 94% 91% 94% 95% 91% 97% 96% 97% 96% 93% 98% 97% 97% 94% 93% 93% 94% 95% 97% 91% 95% 94% 96% 96% 96% 91% 94% 97% 97% 97% 94% 93% 96% 93% 97% 96% 98% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.608896
GSM549102patient 115, normal, homogenized [OPG study]9.4867892
GSM549104patient 119, normal, homogenized [OPG study]10.428495
GSM549108patient 138, normal, homogenized [OPG study]9.8426794
GSM549119patient 077, normal, homogenized [OPG study]9.5836892
GSM549133patient 032, cancer, homogenized [OPG study]10.792197
GSM549139patient 042, cancer, homogenized [OPG study]10.881497
GSM549099patient 107, normal, homogenized [OPG study]10.036994
GSM549109patient 139, normal, homogenized [OPG study]9.4375491
GSM549110patient 046, normal, homogenized [OPG study]9.9981794
GSM549114patient 063, normal, homogenized [OPG study]10.450595
GSM549122patient 082, normal, homogenized [OPG study]9.3400291
GSM549134patient 033, cancer, homogenized [OPG study]11.099497
GSM549136patient 036, cancer, homogenized [OPG study]10.639896
GSM549140patient 044, cancer, homogenized [OPG study]10.953597
GSM549111patient 047, normal, homogenized [OPG study]10.667696
GSM549113patient 057, normal, homogenized [OPG study]9.9711393
GSM549132patient 031, cancer, homogenized [OPG study]11.054398
GSM549137patient 038, cancer, homogenized [OPG study]10.849697
GSM549142patient 047, cancer, homogenized [OPG study]10.208697
GSM549100patient 110, normal, homogenized [OPG study]9.9164494
GSM549107patient 135, normal, homogenized [OPG study]9.7915493
GSM549115patient 068, normal, homogenized [OPG study]10.006293
GSM549116patient 072, normal, homogenized [OPG study]10.013594
GSM549120patient 078, normal, homogenized [OPG study]10.321995
GSM549131patient 030, cancer, homogenized [OPG study]10.949297
GSM549118patient 074, normal, homogenized [OPG study]9.4574991
GSM549129patient 027, cancer, homogenized [OPG study]10.015595
GSM549123patient 088, normal, homogenized [OPG study]9.9783794
GSM549124patient 006, cancer, homogenized [OPG study]10.424896
GSM549126patient 015, cancer, homogenized [OPG study]10.574296
GSM549128patient 025, cancer, homogenized [OPG study]10.436196
GSM549103patient 117, normal, homogenized [OPG study]9.2150591
GSM549117patient 073, normal, homogenized [OPG study]10.248394
GSM549138patient 041, cancer, homogenized [OPG study]10.824597
GSM549141patient 045, cancer, homogenized [OPG study]10.751697
GSM549130patient 028, cancer, homogenized [OPG study]10.741297
GSM549101patient 111, normal, homogenized [OPG study]9.9547794
GSM549105patient 128, normal, homogenized [OPG study]9.7221493
GSM549106patient 134, normal, homogenized [OPG study]10.791696
GSM549112patient 048, normal, homogenized [OPG study]9.9607593
GSM549125patient 011, cancer, homogenized [OPG study]10.693897
GSM549127patient 024, cancer, homogenized [OPG study]10.488796
GSM549135patient 035, cancer, homogenized [OPG study]11.308198